Royalties from Novartis of $66 million for Jakavi and $1 million for Tabrecta and royalties from Lilly of $26 million for Olumiant.
Utilize the input text as a context reference, choose the right relationship between 'Tabrecta' and 'Novartis' from the options.
Options: manufacturer, stock exchange, legal form, developer